Cohen-Solal A - Search Results

1

New treatments for heart failure and exercise capacity.

Cohen-Solal A, Beauvais F. Cohen-Solal A, et al. Eur J Heart Fail. 2021 Dec;23(12):2083-2084. doi: 10.1002/ejhf.2374. Epub 2021 Nov 10. Eur J Heart Fail. 2021. PMID: 34725906 Free article. No abstract available.

2

[How to evaluate the hemodynamic risk after myocardial infarction?].

Cohen-Solal A, Himbert D, Baleynaud S, Dahan M, Juliard JM, Steg PG, Beauvais F, Gourgon R. Cohen-Solal A, et al. Arch Mal Coeur Vaiss. 1992 Nov;85(11 Suppl):1663-7. Arch Mal Coeur Vaiss. 1992. PMID: 1304139 French.

3

Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group.

Cohen-Solal A, Zannad F, Kayanakis JG, Gueret P, Aupetit JF, Kolsky H. Cohen-Solal A, et al. Eur Heart J. 1991 Oct;12(10):1055-63. doi: 10.1093/oxfordjournals.eurheartj.a059837. Eur Heart J. 1991. PMID: 1782929 Clinical Trial.

4

Improving exercise tolerance in patients with chronic heart failure: should we treat the heart or the periphery? VO2 French Study Group.

Cohen-Solal A. Cohen-Solal A. Eur Heart J. 1989 Oct;10(10):866-71. Eur Heart J. 1989. PMID: 2689177 Review. No abstract available.

5

Can anaerobic threshold be used as an end-point for therapeutic trials in heart failure? Lessons from a multicentre randomized placebo-controlled trial. The VO2 French Study Group.

Cohen-Solal A, Aupetit JF, Gueret P, Kolsky H, Zannad F. Cohen-Solal A, et al. Eur Heart J. 1994 Feb;15(2):236-41. doi: 10.1093/oxfordjournals.eurheartj.a060482. Eur Heart J. 1994. PMID: 8005126 Clinical Trial.

6

Cardiac and peripheral responses to exercise in patients with chronic heart failure.

Cohen-Solal A, Logeart D, Guiti C, Dahan M, Gourgon R. Cohen-Solal A, et al. Eur Heart J. 1999 Jul;20(13):931-45. doi: 10.1053/euhj.1998.1473. Eur Heart J. 1999. PMID: 10361045 Review. No abstract available.

7

The management of patients with heart failure in France.

Cohen-Solal A, Bouhour JB, Thebaut JF. Cohen-Solal A, et al. Eur J Heart Fail. 2000 Jun;2(2):223-6. doi: 10.1016/s1388-9842(00)00061-1. Eur J Heart Fail. 2000. PMID: 10856738 Free article.

8

A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.

Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M. Cohen-Solal A, et al. Eur Heart J. 2002 May;23(10):806-14. doi: 10.1053/euhj.2001.2966. Eur Heart J. 2002. PMID: 12009721

9

Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect.

Meune C, Mahé I, Mourad JJ, Cohen-Solal A, Levy B, Kevorkian JP, Jondeau G, Habib A, Lebret M, Knellwolf AL, Simoneau G, Caulin C, Bergmann JF. Meune C, et al. Eur J Heart Fail. 2003 Jun;5(3):271-9. doi: 10.1016/s1388-9842(03)00006-0. Eur J Heart Fail. 2003. PMID: 12798824 Free article.

10

A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure.

Tabet JY, Beauvais F, Thabut G, Tartière JM, Logeart D, Cohen-Solal A. Tabet JY, et al. Eur J Cardiovasc Prev Rehabil. 2003 Aug;10(4):267-72. doi: 10.1097/00149831-200308000-00008. Eur J Cardiovasc Prev Rehabil. 2003. PMID: 14555881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

442 results

Search Page